In ₹ Crore except Per Share Latest Annual	KREBSBIO FY26	ALPA FY26	BALPHARMA FY26	VINEETLAB FY26	Peer Average
Valuation — at last close
P/E	—	◆ 7.78×	21.82×	36.06×	21.88×
P/B	—	◆ 0.59×	1.67×	1.52×	1.26×
EV/EBITDA	◆ -64.63×	-7.76×	9.13×	11.50×	4.29× -1607%
Market Cap	₹128 Cr	₹110 Cr	₹137 Cr	₹69.3 Cr	₹105 Cr +21%
Growth
Revenue CAGR 3Y	-23.07%	◆ 4.61%	0.81%	-34.59%	-9.72% -137%
Revenue CAGR 5Y	-15.07%	1.64%	◆ 4.46%	-24.58%	-6.16% -145%
Net Income CAGR 3Y	—	5.92%	◆ 34.12%	8.59%	16.21%
Revenue YoY (latest Q)	38.94%	25.22%	34.53%	◆ 39.66%	33.14% +18%
Net Income YoY (latest Q)	12.12%	-91.67%	◆ 445.66%	274.84%	209.61% -94%
Profitability
EBITDA Margin	-22.97%	3.11%	10.24%	◆ 14.27%	9.21% -349%
Net Income Margin	-71.35%	◆ 14.19%	2.03%	2.70%	6.31% -1231%
Return on Common Equity	◆ 10.96%	8.39%	7.87%	5.32%	7.19% +52%
Return on Capital Employed	-20.53%	0.66%	◆ 17.17%	15.62%	11.15% -284%
Return on Assets	-10.19%	◆ 6.46%	1.78%	1.46%	3.23% -415%
Credit & Quality
Total Debt/Equity	◆ -1.38×	0.01×	1.94×	0.99×	0.98× -241%
Interest Coverage	-1.68×	◆ 4.64×	1.24×	1.24×	2.37× -171%
Scale — latest FY
Revenue / Total Income	₹23.7 Cr	₹106 Cr	₹312 Cr	₹59.4 Cr	₹159 Cr -85%
Net Income	−₹16.9 Cr	₹15 Cr	₹6.3 Cr	₹1.6 Cr	₹7.6 Cr -322%
Total Assets	₹163 Cr	₹242 Cr	₹376 Cr	₹125 Cr	₹247 Cr -34%
EPS	₹-7.85	₹6.71	₹3.95	₹1	₹3.89 -302%
Book Value per Share	₹-75.49	₹88.53	₹51.65	₹23.74	₹54.64 -238%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.